Evidence map›Paper›PMID 38198375›Full record

ArticleRevista do Instituto de Medicina Tropical de Sao Paulo2024

Severe esophagitis induced by antituberculosis drugs: a case report.

Roxana Flores Mamani, Franciele Moreira Silva, Marcos Vidal de Lima-Júnior, Juliana Paitach de Oliveira Lima, Vitor Montez Vianna, Rivelino Trindade de Azevedo, Billy McBenedict, Ezequias Batista Martins

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Revista do Instituto de Medicina Tropical de Sao Paulo, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Roxana Flores MamaniHospital Municipal Ronaldo Gazolla, Rio de Janeiro, Rio de Janeiro, Brazil.ORCID http://orcid.org/0000-0003-0794-8366
Franciele Moreira SilvaHospital Municipal Ronaldo Gazolla, Rio de Janeiro, Rio de Janeiro, Brazil.ORCID http://orcid.org/0009-0001-1209-9453
Marcos Vidal de Lima-JúniorHospital Municipal Ronaldo Gazolla, Rio de Janeiro, Rio de Janeiro, Brazil.ORCID http://orcid.org/0009-0009-5802-1078
Juliana Paitach de Oliveira LimaHospital Municipal Ronaldo Gazolla, Rio de Janeiro, Rio de Janeiro, Brazil.ORCID http://orcid.org/0009-0005-8162-4142
Vitor Montez ViannaHospital Municipal Ronaldo Gazolla, Rio de Janeiro, Rio de Janeiro, Brazil.ORCID http://orcid.org/0009-0005-1819-1495
Rivelino Trindade de AzevedoHospital Municipal Ronaldo Gazolla, Rio de Janeiro, Rio de Janeiro, Brazil.ORCID http://orcid.org/0000-0003-1819-0204
Billy McBenedictUniversidade Federal Fluminense, Faculdade de Medicina, Niterói, Rio de Janeiro, Brazil.ORCID http://orcid.org/0000-0002-8987-5545
Ezequias Batista MartinsUniversidade Federal Fluminense, Faculdade de Medicina, Niterói, Rio de Janeiro, Brazil.ORCID http://orcid.org/0000-0003-3373-0408
Universidade Federal Fluminense · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tuberculosis stands as one of humanity's oldest afflictions, intrinsically intertwined with social disparities. This formidable disease spares no age group and remains the prevailing cause of infection-induced mortality worldwide, particularly in developing nations. We present a case of a 56-year-old woman with diabetes who was diagnosed with Pulmonary Tuberculosis. After receiving antituberculosis drugs as part of her treatment, she experienced a range of systemic manifestations and suffered from severe ulcerative esophagitis. This adverse reaction led to uncontrollable gastrointestinal intolerance, tragically resulting in her untimely demise. The incident underscores the potential seriousness of adverse reactions that can arise from tuberculosis treatment medications.

Indexed as

EsophagitisTuberculosis, PulmonaryAntitubercular AgentsFemaleHumansMiddle AgedAntitubercular Agents

Identifiers

PMID38198375
PMCPMC10768651
OpenAlexW4390603956

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.